| Description |
xix, 410 p. : ill. |
| Series |
Chapman & Hall/CRC biostatistics series ; 60
|
| Note |
"A Chapman & Hall book." |
| Bibliography |
Includes bibliographical references. |
| Summary |
"Biologic drug products are therapeutic moieties that are manufactured using a living system or organism. These are important life-saving drug products for patients with unmet medical needs. They also comprise a growing segment in the pharmaceutical industry. In 2007, for instance, worldwide sales of biological products reached $94 billion US dollars, accounting for about 15% of the pharmaceutical industry's gross revenue. Meanwhile, many biological products face losing their patents in the next decade"-- Provided by publisher. |
| Reproduction |
Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries. |
| Subject |
Pharmaceutical biotechnology.
|
|
Pharmaceutical biotechnology industry.
|
|
Drugs -- Generic substitution.
|
|
Pharmaceutical policy.
|
|
Biological products.
|
| Genre/Form |
Electronic books.
|
| Added Author |
ProQuest (Firm)
|
| ISBN |
9781466579699 (hardback) |
|
9781466579705 (e-book) |
|
